IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — ANNX

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.200.180.140.130.100.080.160.150.130.110.210.100.110.070.100.21
Total Current Assets0.210.230.190.230.270.340.370.270.170.200.270.180.210.280.300.33
Property, Plant & Equipment0.010.010.010.010.010.010.010.010.020.020.020.020.020.010.010.00
Total Non-current Assets*0.030.030.040.030.030.030.030.030.030.040.040.040.040.030.030.00
Total Assets0.250.260.230.260.300.380.410.300.200.230.310.220.250.310.330.33
Accounts Payable0.020.020.020.010.010.010.000.000.000.010.010.010.010.000.000.00
Total Current Liabilities0.040.040.040.040.030.020.020.010.020.020.020.020.020.010.010.01
Total Non-current Liabilities*0.020.020.020.020.030.030.030.030.030.030.030.030.030.030.030.00
Total Liabilities0.060.060.070.070.060.050.050.040.050.050.050.050.050.050.040.01
Retained Earnings(1.02)(0.96)(0.87)(0.81)(0.77)(0.66)(0.63)(0.60)(0.54)(0.51)(0.40)(0.37)(0.33)(0.26)(0.22)(0.19)
Total Stockholder Equity0.190.200.160.200.240.330.360.260.160.180.260.170.200.260.300.32

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Research & Development46.5935.7942.6649.7044.1648.1843.3530.1125.0320.9623.2727.8930.2528.5427.8629.1127.0027.2227.5824.57
Selling, General & Admin10.6410.277.607.327.579.239.139.348.557.616.746.897.448.168.218.308.4310.308.106.80
Total Operating Expenses57.2346.0550.2657.0251.7357.4152.4839.4433.5828.5730.0134.7837.6936.7036.0737.4135.4337.5135.6831.37
Operating Income(57.23)(46.05)(50.26)(57.02)(51.73)(57.40)(52.48)(39.44)(33.58)(28.57)(30.01)(34.78)(37.69)(36.69)(36.07)(37.41)(35.43)(37.51)(35.68)(31.37)
Pretax Income------------------------------------(35.60)(31.29)
Net Income(55.35)(44.14)(48.26)(54.92)(49.16)(54.36)(48.59)(34.82)(29.61)(25.18)(27.89)(32.48)(35.19)(34.38)(35.05)(37.14)(35.37)(37.42)(35.60)(31.29)
Basic EPS(0.28)(0.23)(0.26)(0.37)(0.34)(0.37)(0.32)(0.25)(0.23)(0.21)(0.35)(0.43)(0.47)(0.39)(0.51)(0.96)--------
Diluted EPS(0.28)(0.23)(0.26)(0.37)(0.34)(0.37)(0.32)(0.25)(0.23)(0.21)(0.35)(0.43)(0.47)(0.39)(0.51)(0.96)--------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(48.01)(46.80)(45.93)(52.30)(38.07)(50.05)(36.01)(32.01)(21.71)(28.27)(23.48)(32.99)(69.37)(27.14)(30.72)(28.16)(30.29)(28.32)(29.71)(24.66)
Capital Expenditures0.140.000.000.050.020.070.010.01----0.010.140.170.280.170.865.210.860.770.00
Free Cash Flow*(48.14)(46.80)(45.93)(52.35)(38.09)(50.13)(36.02)(32.02)----(23.48)(33.13)(69.54)(27.42)(30.89)(29.02)(35.50)(29.18)(30.48)(24.66)
Investing Cash Flow39.9727.06(26.52)45.8773.0897.621.01(45.93)(96.58)(77.30)(2.18)19.5225.05(43.61)14.1019.7168.2533.70(1.28)(83.07)
Financing Cash Flow32.1032.9095.0813.560.150.064.970.18123.6532.41117.6017.5817.930.11122.670.110.020.95(0.07)0.65

* Derived from reported values